Cancer Vaccines Market, Size, Share, Outlook and Growth Opportunities 2019-2026

SKU: DPC301 | Last Updated On: Feb 17 2020 | No. of Pages: 184 | Available Formats

> Global Cancer Vaccines Market Expected to reach at a high CAGR by 2026: DataM Intelligence

Global Cancer Vaccines Market is segmented By Technology (Dendritic Cells Vaccines, Anti-idiotype Vaccines, Antigen Vaccines, Whole Tumor Vaccines, DNA Vaccines), By Type (Preventive Cancer Vaccines, Treatment Cancer Vaccines), By Disease Type (Cervical Cancer, Prostate Cancer, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2019-2026

 

Market Overview

The Global Cancer Vaccines Market is expected to grow at a high CAGR during the forecasting period (2019-2026).

Why purchase the report?

  • Visualize the composition of the Cancer Vaccines Market across each indication, regarding type and application highlighting the critical commercial assets and players.

  • Identify business opportunities in Cancer Vaccines Market by analyzing trends and co-development deals.

  • Excel data sheet with thousands of data points of the Cancer Vaccines Market levels 4/5 segmentation.

  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • Product mapping in excel for the essential Cancer Vaccines Market of all major market players.

Who can benefit from this report?

  • Raw Material Suppliers/ Buyers

  • Product Suppliers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers

 

Table of Contents

  1. Global Cancer Vaccines Market Methodology and Scope

    1. Research Methodology

    2. Research Objective and Scope of the Report

  2. Global Cancer Vaccines Market – Market Definition and Overview

  3. Global Cancer Vaccines Market – Executive Summary

    1. Market Snippet by Technology

    2. Market Snippet by Type

    3. Market Snippet by Disease Type

    4. Market Snippet by Region

    5. DataM CLO Scenario

  4. Global Cancer Vaccines Market – Market Dynamics

    1. Market Impacting Factors

      1. Drivers

        1. Rising prevalence of cancer

        2. Robust pipeline

        3. Surge in investments by government and non-government organizations

      2. Restraints

        1. Long manufacturing timeline

        2. High investment requirement for manufacturing process

      3. Opportunity

      4. Impact Analysis

  5. Global Cancer Vaccines Market – Industry Analysis 

    1. Porter's Five Forces Analysis

    2. Regulatory Analysis

    3. Epidemiology

  6. Global Cancer Vaccines Market – Pipeline Analysis 

  7. Global Cancer Vaccines Market – By Technology

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      2. Market Attractiveness Index, By Technology

    2. Dendritic Cells Vaccines

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

    3.  Anti-idiotype Vaccines

    4.  Antigen Vaccines

    5.  Whole Tumor Vaccines

    6.  DNA Vaccines

  8. Global Cancer Vaccines Market – By Type

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

      2. Market Attractiveness Index, By Type

    2. Preventive Cancer Vaccines

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

    3. Treatment Cancer Vaccines

  9. Global Cancer Vaccines Market – By Disease Type

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

      2. Market Attractiveness Index, By Disease Type

    2. Cervical Cancer

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

    3.  Prostate Cancer

    4.  Others

  10. Global Cancer Vaccines Market – By Region

    1. Introduction 

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

      2. Market Attractiveness Index, By Region

    2. North America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. U.S.

        2. Canada

        3. Mexico

    3. Europe

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Germany

        2. U.K.

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

    4. South America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Brazil

        2. Argentina

        3. Rest of South America

    5. Asia-Pacific

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China

        2. India

        3. Japan

        4. Australia

        5. Rest of Asia Pacific

    6. Middle East and Africa

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type

  11. Global Market – Competitive Landscape

    1. Competitive Scenario

    2. Competitor Cancer Vaccines Strategy Analysis

    3. Comparative Product Portfolio Analysis

    4. Market Positioning/Share Analysis

    5. Mergers and Acquisitions Analysis

  12. Global Market – Company Profiles

    1. Amgen Inc. *

      1. Company Overview

      2. Product Portfolio and Description

      3. Key Highlights

      4. Financial Overview

    2. GlaxoSmithKline Plc

    3. Merck & Co., Inc.

    4. Kite Pharma Inc.

    5. Novartis AG

    6. Juno Therapeutics Inc.

    7. Bausch Health Companies Inc.

    8. Bharat Biotech International Limited

    9. VBI Vaccines Inc.

    10. Dynavax Technologies Corporation

    11. Sinovac Biotech Ltd.

    12. Astrazeneca Plc

    13. Sanofi Pasteur SA

    14. Astellas Pharma Inc.

    15. CSL Limited

    16. Pfizer Inc.

  13. Global Cancer Vaccines Market – Premium Insights

  14. Global Cancer Vaccines Market – DataM

    1. Appendix

    2. About Us and Services

    3. Contact Us

List of Tables & Figures

List of Tables

Table 1 Global Cancer Vaccines Market Value, By Technology, 2018,2022 & 2026 ($ Million)

Table 2 Global Cancer Vaccines Market Value, By Type, 2018,2022 & 2026 ($ Million)

Table 3 Global Cancer Vaccines Market Value, By Disease Type, 2018,2022 & 2026 ($ Million)

Table 4 Global Cancer Vaccines Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 5 Global Cancer Vaccines Market Value, By Technology, 2018,2022 & 2026 ($ Million)

Table 6 Global Cancer Vaccines Market Value, By Technology, 2017-2026 ($ Million)

Table 7 Global Cancer Vaccines Market Value, By Type, 2018,2022 & 2026 ($ Million)

Table 8 Global Cancer Vaccines Market Value, By Type, 2017-2026 ($ Million)

Table 9 Global Cancer Vaccines Market Value, By Disease Type, 2018,2022 & 2026 ($ Million)

Table 10 Global Cancer Vaccines Market Value, By Disease Type, 2017-2026 ($ Million)

Table 11 Global Cancer Vaccines Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 12 Global Cancer Vaccines Market Value, By Region, 2017-2026 ($ Million)

Table 13 North America Cancer Vaccines Market Value, By Technology, 2017-2026 ($ Million)

Table 14 North America Cancer Vaccines Market Value, By Type, 2017-2026 ($ Million)

Table 15 North America Cancer Vaccines Market Value, By Disease Type, 2017-2026 ($ Million)

Table 16 North America Cancer Vaccines Market Value, By Country, 2017-2026 ($ Million)

Table 17 South America Cancer Vaccines Market Value, By Technology, 2017-2026 ($ Million)

Table 18 South America Cancer Vaccines Market Value, By Type, 2017-2026 ($ Million)

Table 19 South America Cancer Vaccines Market Value, By Disease Type, 2017-2026 ($ Million)

Table 20 South America Cancer Vaccines Market Value, By Country, 2017-2026 ($ Million)

Table 21 Europe Cancer Vaccines Market Value, By Technology, 2017-2026 ($ Million)

Table 22 Europe Cancer Vaccines Market Value, By Type, 2017-2026 ($ Million)

Table 23 Europe Cancer Vaccines Market Value, By Disease Type, 2017-2026 ($ Million)

Table 24 Europe Cancer Vaccines Market Value, By Country, 2017-2026 ($ Million)

Table 25 Asia-Pacific Cancer Vaccines Market Value, By Technology, 2017-2026 ($ Million)

Table 26 Asia-Pacific Cancer Vaccines Market Value, By Type, 2017-2026 ($ Million)

Table 27 Asia-Pacific Cancer Vaccines Market Value, By Disease Type, 2017-2026 ($ Million)

Table 28 Asia-Pacific Cancer Vaccines Market Value, By Country, 2017-2026 ($ Million)

Table 29 Middle East & Africa Cancer Vaccines Market Value, By Technology, 2017-2026 ($ Million)

Table 30 Middle East & Africa Cancer Vaccines Market Value, By Type, 2017-2026 ($ Million)

Table 31 Middle East & Africa Cancer Vaccines Market Value, By Disease Type, 2017-2026 ($ Million)

Table 32 Amgen Inc.: Overview

Table 33 Amgen Inc.: Product Portfolio

Table 34 Amgen Inc.: Key Developments

Table 35 GlaxoSmithKline Plc: Overview

Table 36 GlaxoSmithKline Plc: Product Portfolio

Table 37 GlaxoSmithKline Plc: Key Developments

Table 38 Merck & Co., Inc.: Overview

Table 39 Merck & Co., Inc.: Product Portfolio

Table 40 Merck & Co., Inc.: Key Developments

Table 41 Kite Pharma Inc.: Overview

Table 42 Kite Pharma Inc.: Product Portfolio

Table 43 Kite Pharma Inc.: Key Developments

Table 44 Novartis AG: Overview

Table 45 Novartis AG: Product Portfolio

Table 46 Novartis AG: Key Developments

Table 47 Juno Therapeutics Inc.: Overview

Table 48 Juno Therapeutics Inc.: Product Portfolio

Table 49 Juno Therapeutics Inc.: Key Developments

Table 50 Bausch Health Companies Inc.: Overview

Table 51 Bausch Health Companies Inc.: Product Portfolio

Table 52 Bausch Health Companies Inc.: Key Developments

Table 53 Bluebird Bio Inc.: Overview

Table 54 Bluebird Bio Inc.: Product Portfolio

Table 55 Bluebird Bio Inc.: Key Developments

Table 56 Bavarian Nordic AS: Overview

Table 57 Bavarian Nordic AS: Product Portfolio

Table 58 Bavarian Nordic AS: Key Developments

Table 59 Gritstone Oncology Inc.: Overview

Table 60 Gritstone Oncology Inc.: Product Portfolio

Table 61 Gritstone Oncology Inc.: Key Developments

 

List of Figures

Figure 1 Global Cancer Vaccines Market Share, By Technology, 2018 & 2026 (%)

Figure 2 Global Cancer Vaccines Market Share, By Type, 2018 & 2026 (%)

Figure 3 Global Cancer Vaccines Market Share, By Disease Type, 2018 & 2026 (%)

Figure 4 Global Cancer Vaccines Market Share, By Region, 2018 & 2026 (%)

Figure 5 Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 6 Global Cancer Vaccines Market Y-o-Y Growth, By Technology, 2018-2026 (%)

Figure 7 Dendritic Cells Vaccines: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 8 Anti-idiotype Vaccines: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 9 Antigen Vaccines: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 10 Whole Tumor Vaccines: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 11 DNA Vaccines: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 12 Global Cancer Vaccines Market Y-o-Y Growth, By Type, 2018-2026 (%)

Figure 13 Preventive Cancer Vaccines: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 14 Treatment Cancer Vaccines: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 15 HPV Vaccine: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 16 Hepatitis B Vaccine: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 17 Global Cancer Vaccines Market Y-o-Y Growth, By Disease Type, 2018-2026 (%)

Figure 18 Cervical Cancer: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 19 Prostate Cancer: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 20 Others: Global Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 21 Global Cancer Vaccines Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 22 North America Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 23 North America Cancer Vaccines Market Share, By Technology, 2018 & 2026 (%)

Figure 24 North America Cancer Vaccines Market Share, By Type, 2018 & 2026 (%)

Figure 25 North America Cancer Vaccines Market Share, By Disease Type, 2018 & 2026 (%)

Figure 26 North America Cancer Vaccines Market Share, By Country, 2018 & 2026 (%)

Figure 27 South America Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 28 South America Cancer Vaccines Market Share, By Technology, 2018 & 2026 (%)

Figure 29 South America Cancer Vaccines Market Share, By Type, 2018 & 2026 (%)

Figure 30 South America Cancer Vaccines Market Share, By Disease Type, 2018 & 2026 (%)

Figure 31 South America Cancer Vaccines Market Share, By Country, 2018 & 2026 (%)

Figure 32 Europe Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 33 Europe Cancer Vaccines Market Share, By Technology, 2018 & 2026 (%)

Figure 34 Europe Cancer Vaccines Market Share, By Type, 2018 & 2026 (%)

Figure 35 Europe Cancer Vaccines Market Share, By Disease Type, 2018 & 2026 (%)

Figure 36 Europe Cancer Vaccines Market Share, By Country, 2018 & 2026 (%)

Figure 37 Asia-Pacific Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 38 Asia-Pacific Cancer Vaccines Market Share, By Technology, 2018 & 2026 (%)

Figure 39 Asia-Pacific Cancer Vaccines Market Share, By Type, 2018 & 2026 (%)

Figure 40 Asia-Pacific Cancer Vaccines Market Share, By Disease Type, 2018 & 2026 (%)

Figure 41 Asia-Pacific Cancer Vaccines Market Share, By Country, 2018 & 2026 (%)

Figure 42 Middle East & Africa Cancer Vaccines Market Value, 2017-2026 ($ Million)

Figure 43 Middle East & Africa Cancer Vaccines Market Share, By Technology, 2018 & 2026 (%)

Figure 44 Middle East & Africa Cancer Vaccines Market Share, By Type, 2018 & 2026 (%)

Figure 45 Middle East & Africa Cancer Vaccines Market Share, By Disease Type, 2018 & 2026 (%)

Figure 46 Amgen Inc.: Financials

Figure 47 GlaxoSmithKline Plc: Financials

Figure 48 Merck & Co., Inc.: Financials

Figure 49 Kite Pharma Inc.: Financials

Figure 50 Novartis AG: Financials

Figure 51 Juno Therapeutics Inc.: Financials

Figure 52 Bausch Health Companies Inc.: Financials

Figure 53 Bluebird Bio Inc.: Financials

Figure 54 Bavarian Nordic AS: Financials

Figure 55 Gritstone Oncology Inc.: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!

linkedinpinterest